- Home
- REI vs SERA Comparison
REI vs SERA Comparison
Compare REI & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REI
- SERA
- Stock Information
- Founded
- REI 2004
- SERA 2008
- Country
- REI United States
- SERA United States
- Employees
- REI N/A
- SERA N/A
- Industry
- REI Oil & Gas Production
- SERA Precision Instruments
- Sector
- REI Energy
- SERA Health Care
- Exchange
- REI Nasdaq
- SERA Nasdaq
- Market Cap
- REI 247.7M
- SERA 208.7M
- IPO Year
- REI N/A
- SERA 2021
- Fundamental
- Price
- REI $1.49
- SERA $6.42
- Analyst Decision
- REI
- SERA
- Analyst Count
- REI 0
- SERA 0
- Target Price
- REI N/A
- SERA N/A
- AVG Volume (30 Days)
- REI 2.1M
- SERA 153.6K
- Earning Date
- REI 03-06-2025
- SERA 11-06-2024
- Dividend Yield
- REI N/A
- SERA N/A
- EPS Growth
- REI 52.41
- SERA N/A
- EPS
- REI 0.57
- SERA N/A
- Revenue
- REI $365,608,400.00
- SERA $94,000.00
- Revenue This Year
- REI $8.89
- SERA N/A
- Revenue Next Year
- REI N/A
- SERA $4,471.43
- P/E Ratio
- REI $2.61
- SERA N/A
- Revenue Growth
- REI 6.76
- SERA N/A
- 52 Week Low
- REI $1.21
- SERA $4.98
- 52 Week High
- REI $2.20
- SERA $12.36
- Technical
- Relative Strength Index (RSI)
- REI 57.94
- SERA 37.74
- Support Level
- REI $1.44
- SERA $6.03
- Resistance Level
- REI $1.52
- SERA $6.83
- Average True Range (ATR)
- REI 0.07
- SERA 0.59
- MACD
- REI 0.02
- SERA -0.22
- Stochastic Oscillator
- REI 81.25
- SERA 14.44
About REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform, and the Delaware Basin all of which are part of the Permian Basin in Texas.
About SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.